Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes
Chang‐Keun Cho, Hye-Jung Park, Pureum Kang, et al.
Archives of Pharmacal Research (2021) Vol. 44, Iss. 12, pp. 1076-1090
Closed Access | Times Cited: 22

Showing 22 citing articles:

Comparisons of PK-Sim® and R Program for Physiologically Based Pharmacokinetic Model Development for Broiler Chickens and Laying Hens: Meloxicam as a Case Study
Zhicheng Zhang, Lisa A. Tell, Zhoumeng Lin
Toxicological Sciences (2025)
Closed Access | Times Cited: 2
Comprehensive Parent‐Metabolite PBPK/PD Modeling Insights Into Methotrexate Personalized Dosing Strategies in Patients With Rheumatoid Arthritis
Xin Wang, Jiangfan Wu, Hongjiang Ye, et al.
CPT Pharmacometrics & Systems Pharmacology (2025)
Open Access | Times Cited: 1
PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug–drug interactions with clarithromycin and paroxetine
Chang-Keun Cho, Pureum Kang, Choon‐Gon Jang, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 5, pp. 481-504
Closed Access | Times Cited: 4
Physiologically based pharmacokinetic (PBPK) modeling of gliclazide for different genotypes of CYP2C9 and CYP2C19
Hye-Jung Park, Sangho Lee, Pureum Kang, et al.
Archives of Pharmacal Research (2025)
Closed Access
Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism
Chang‐Keun Cho, Pureum Kang, Hye-Jung Park, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 5, pp. 352-366
Closed Access | Times Cited: 16
Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects
Pureum Kang, Chang‐Keun Cho, Choon‐Gon Jang, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 5, pp. 438-447
Closed Access | Times Cited: 8
Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes
Choong‐Min Lee, Pureum Kang, Chang‐Keun Cho, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 6, pp. 433-445
Closed Access | Times Cited: 13
Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects
Chang‐Keun Cho, Ji‐Young Byeon, Pureum Kang, et al.
Archives of Pharmacal Research (2022) Vol. 46, Iss. 2, pp. 111-116
Closed Access | Times Cited: 13
Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects
Nam-Tae Kim, Chang‐Keun Cho, Pureum Kang, et al.
Archives of Pharmacal Research (2021) Vol. 45, Iss. 2, pp. 114-121
Closed Access | Times Cited: 17
Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone
Ji‐Young Byeon, Chang‐Keun Cho, Pureum Kang, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 8, pp. 713-721
Closed Access | Times Cited: 6
Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes
Chang‐Keun Cho, Pureum Kang, Choon‐Gon Jang, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 11-12, pp. 939-953
Closed Access | Times Cited: 6
Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes
Sang-Sup Whang, Chang‐Keun Cho, Eui Hyun Jung, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 8, pp. 584-595
Closed Access | Times Cited: 10
Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone
Chang‐Keun Cho, Ji‐Young Byeon, Pureum Kang, et al.
Archives of Pharmacal Research (2022) Vol. 46, Iss. 1, pp. 59-64
Closed Access | Times Cited: 10
PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes
Chang‐Keun Cho, Eunvin Ko, Ju Yeon Mo, et al.
Archives of Pharmacal Research (2023) Vol. 47, Iss. 1, pp. 82-94
Closed Access | Times Cited: 5
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic‐pharmacodynamic model
Ji-Hoon Jang, Seung‐Hyun Jeong, Yong‐Bok Lee
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023) Vol. 43, Iss. 2, pp. 145-157
Closed Access | Times Cited: 4
Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism
Chang‐Keun Cho, Ju Yeon Mo, Eunvin Ko, et al.
Archives of Pharmacal Research (2023) Vol. 47, Iss. 2, pp. 95-110
Closed Access | Times Cited: 4
Development and application of a physiologically-based pharmacokinetic model for ractopamine in goats
Jing Ai, Yunfeng Gao, Fan Yang, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 1
Anti-Inflammatory, Neurotrophic, and Cytotoxic Oxylipins Isolated from Chaenomeles sinensis Twigs
Da Yeong Lee, Kyoung-Jin Park, Lalita Subedi, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 284-284
Open Access | Times Cited: 2
Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes
Chang-Keun Cho, Pureum Kang, Choon‐Gon Jang, et al.
Archives of Pharmacal Research (2024)
Closed Access
CYP2C9 Polymorphism Influence in PK/PD Model of Naproxen and 6-O-Desmethylnaproxen in Oral Fluid
Gabriela Moraes Oliveira, Thiago José Dionísio, Viviane Silva Siqueira-Sandrin, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1106-1106
Open Access | Times Cited: 2
Torsemide Pharmacometrics in Healthy Adult Populations Including CYP2C9 Genetic Polymorphisms and Various Patient Groups through Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling
Seung‐Hyun Jeong, Ji-Hun Jang, Yong‐Bok Lee
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2720-2720
Open Access | Times Cited: 2
Liquid Chromatography-Tandem Mass Spectrometry Method for Detection and Quantification of Meloxicam and 5′-Carboxymeloxicam in Oral Fluid Samples
Gabriela Moraes Oliveira, Thiago José Dionísio, Viviane Silva Siqueira-Sandrin, et al.
Metabolites (2023) Vol. 13, Iss. 6, pp. 755-755
Open Access
Page 1

Scroll to top